期刊文献+

肝素对脂多糖诱导内皮细胞损伤中基质金属蛋白酶及其组织抑制剂基因表达的影响 被引量:10

Therapeutic effects of unfractionated heparin on lipopolysaccharide-activated matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in endothelial cells
原文传递
导出
摘要 目的探讨基质金属蛋白酶9(MMP-9)及其组织抑制剂-1(TIMP-1)在脂多糖(LPS)诱导内皮细胞损伤中的表达,并观察肝素对其水平的影响。方法LPS10txg/ml刺激人肺微血管内皮细胞(HPMEC)诱导损伤,肝素预处理组分别于LPS刺激前15min加入0.1U/ml及1U/ml普通肝素,对照组加入等量磷酸盐缓冲液(PBS)。分别在刺激2、6、12h收集细胞提取RNA,应用实时荧光定量逆转录-聚合酶链反应(qRT—PCR)检测各组细胞中MMP~9及TIMP-1的mRNA表达。结果与对照组比较,LPS刺激2h组MMP-9和TIMP-1的mRNA表达明显增高,12h达高峰(MMP-9mRNA:4.26±0.81比1.00±0.46,TIMP-1mRNA:4.93±0.08比1.00±0.13,均P〈0.05),以TIMP-1增高明显。预防性应用肝素可明显降低MMP-9和TIMP-1的mRNA表达(0.1U/ml组:MMP-9mRNA2.74±0.30,TIMP-1mRNA2.96±0.13;1U/ml组iMMP-9mRNA3.08±0.48,TIMP-1mRNA2.93±0.27,均P〈0.05)。不同剂量肝素组间基因表达水平差异无统计学意义。结论LPS诱导内皮细胞损伤时MMP-9、TIMP-1表达增加,肝素可能通过调节MMP-9、TIMP-1表达水平发挥其保护作用。 Objective To investigate the expressions of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 (TIMP-1 ) in injured endothelial cells induced by lipopolysaccharide (LPS) and the effects of unfraetionated heparin (UFH) on the level of expressions. Methods The human pulmonary microvascular endothelial cells (HPMECs) were injured by LPS (10μg/ml). In UFH pretreatment group, the cells were interfered with 0.1 U/ml or 1 U/ml UFH within 15 minutes before stimulus of LPS. In control group, the cells were cultured in equal volume of phosphate buffered saline (PBS). The RNA of the respectively cells were extracted at 2, 6, 12 hours after stimulus, and the expressions of MMP-9 mRNA and TIMP-1 mRNA were detected by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Results Compared with control group, the expressions of MMP-9 mRNA and TIMP-1 mRNA were increased after stimulation of LPS, and peaked at 12 hours (MMP-9 mRNA: 4.26 ± 0.81 vs. 1.00 ± 0.46, TIMP-1 mRNA: 4.93 ± 0.08 vs. 1.00 ± 0.13, both P〈0.05), the change in TIMP-1 was more significant. While as UFH pretreatment could significantly down-regulated the mRNA expressions of MMP-9 and TIMP-1 (UFH 0.1 U/ml group MMP-9 mRNA : 2.74 ± 0.30, TIMP-1 mRNA : 2.96 ± 0.13 ; UFH 1 U/ml group MMP-9 mRNA: 3.08 -± 0.48, TIMP-1 mRNA: 2.93 ± 0.27, all P〈O.05). There were no significant differences in mRNA expressions between two UFH groups. Conclusions The expressions of MMP-9 and TIMP-1 of HPMEC injured by LPS were obviously increased, UFH might attenuate the injury via inhibiting the expressions of MMP-9 and TIMP-1.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2012年第8期490-492,共3页 Chinese Critical Care Medicine
基金 辽宁省科技厅药物源头创新研究课题(20071027-7) 辽宁省医学高峰建设工程项目(2010-1067) 辽宁省沈阳市科技计划项目(1710-205-1-01)
关键词 脂多糖 内皮细胞 普通肝素 基质金属蛋白酶9 金属蛋白酶组织抑制剂-1 Lipopolysaccharide Endothelial cell Unfractionated heparin Matrix metalloproteinase-9 Tissue inhibitors of metalloproteinase-1
  • 相关文献

参考文献20

二级参考文献44

  • 1季宪飞,黄亮江.细胞黏附分子与急性肺损伤[J].中国危重病急救医学,2004,16(7):444-446. 被引量:8
  • 2焦华波,乔治,谭向龙,杜俊东,费阳,王大东,李基业,姚咏明.低分子肝素对急性胰腺炎患者预后的改善作用[J].中国危重病急救医学,2004,16(12):712-714. 被引量:17
  • 3栾正刚,娜拉.普鲁,章志丹,马晓春.低分子肝素和阿司匹林对急性肺损伤的治疗作用[J].中国危重病急救医学,2006,18(8):456-458. 被引量:18
  • 4Kinasewitz GT,Yan SB,Besson B,et al.Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis,regardless of causative micro-organism[ISBCTN74215569].Crit Care,2004,8:R82-90.
  • 5Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine.Chest,1992,101:1644-1655.
  • 6Bernard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med,2001,344:699-709.
  • 7Monaet X,Lamia B,Anguel N,et al.Rapid and beneficial bemodynamic effects of activated protein C in septic shock patients.Intensive Care Med,2005,31:1573-1576.
  • 8Abraham E,Laterre PF,Garg R,et al.Dretrecogin alfa (activated) for adults with severe sepsis and a low risk of death.N Engl J Meal,2005,353:1332-1341.
  • 9Schippar HG,Jenkins CS,Kahle LH,et al.Antithrombin-Ⅲ transfusion in disseminated intravaseular coagulation.Lancet,1978,1:854-856.
  • 10Fourrier F,Chopin C,Huart JJ,et al.Double-blind,placebocontrolled trial of antithrombin Ⅲ concentrates in septic shock with disseminated intravascular coagulation.Chest,1993,104:882-888.

共引文献105

同被引文献98

  • 1刘焱,王学美.400例2型糖尿病患者中医证型与糖尿病慢性并发症、生存质量及实验室指标的相关研究[J].中国中西医结合急救杂志,2010,17(2):76-79. 被引量:25
  • 2艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 3姚橹,王美堂,霍正禄.急性肺损伤/急性呼吸窘迫综合征血凝状态异常及抗凝治疗进展[J].中国急救医学,2007,27(5):460-464. 被引量:8
  • 4Catravas JD,Snead C,Dimitropoulou C. Harvesting,identification and barrier function of human lung microvascular endothelial cells[J].Vascul Pharmacol,2010.175-181.
  • 5Jin Y,Lee SJ,Minshall RD. Caveolin-1:a critical regulator of lung injury[J].{H}American Journal of Physiology Lung Cellular and Molecular Physiology,2011.L151-L160.
  • 6Farley KS,Wang L,Mehta S. Septic pulmonary microvascular endothelial cell injury:role of alveolar macrophage NADPH oxidase[J].{H}American Journal of Physiology Lung Cellular and Molecular Physiology,2009.L480-L488.
  • 7Sun Y,Hu G,Zhang X. Phosphorylation of cavoolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways[J].{H}CIRCULATION RESEARCH,2009.676-685.
  • 8Zhang M,Lin L,Lee SJ. Deletion of caveolin-I protects hyperoxia-induced apoptosis via survivin-mediated pathways[J].{H}American Journal of Physiology Lung Cellular and Molecular Physiology,2009.L945-L953.
  • 9Hu G,Ye RD,Dinauer MC. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury[J].{H}American Journal of Physiology Lung Cellular and Molecular Physiology,2008.L178-L186.
  • 10Lv XJ,Li YY,Zhang YJ. Over-expression of caveolin-1 aggravate LPS-induced inflammatory response in AT-1 cells via up-regulation of cPLA2/p38 MAPK[J].{H}Inflammation Research,2010.531-541.

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部